The cost-utility of sodium oxybate as narcolepsy treatment.
Kristian BolinP BerlingP WaslingH MeinildJ KjellbergP JennumPublished in: Acta neurologica Scandinavica (2017)
The estimated cost per additional QALY for the sodium oxybate treatment alternative compared with standard treatment was estimated above the informal Swedish willingness-to-pay threshold (SEK 500,000). The estimated cost per additional QALY obtained here is likely to overestimate the true cost-effectiveness ratio as potentially beneficial effects on productivity of treatment with sodium oxybate were not included (due to lack of data).